OTC Markets OTCPK - Delayed Quote USD
Cosmo Pharmaceuticals N.V. (CMOPF)
55.00
0.00
(0.00%)
As of April 24 at 4:00:00 PM EDT. Market Open.
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 3 | 2 |
| Avg. Estimate | 59.58M | 61.58M | 197.02M | 129.59M |
| Low Estimate | 59.58M | 61.58M | 103M | 121M |
| High Estimate | 59.58M | 61.58M | 250.3M | 138.19M |
| Year Ago Sales | -- | -- | 266.79M | 197.02M |
| Sales Growth (year/est) | -- | -- | -26.15% | -34.22% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CMOPF | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
OPHLF Ono Pharmaceutical Co., Ltd.
11.81
0.00%
RHHBF Roche Holding AG
355.38
0.00%
NONOF Novo Nordisk A/S
61.55
-3.15%
RHHBY Roche Holding AG
39.55
-0.48%
SNY Sanofi
52.74
-1.49%
NVS Novartis AG
111.65
+0.43%
BIIB Biogen Inc.
118.35
-0.97%
OGN Organon & Co.
12.17
+0.41%
GILD Gilead Sciences, Inc.
102.96
-3.01%
BMY Bristol-Myers Squibb Company
47.34
-2.77%